MRI study to predict bleeding risk in moyamoya disease
Part of Brain & nervous system, Heart & circulation clinical trials.
This study uses advanced MRI scans to better predict the risk of bleeding in people with moyamoya disease, a rare condition where brain arteries narrow. It aims to improve prevention of bleeding strokes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have moyamoya disease or moyamoya syndrome confirmed by a cerebral angiogram.
- You must be able to have a 5-Tesla MRI scan.
- You must not have claustrophobia or other conditions that prevent an MRI.
- You must not have had revascularization surgery on both sides of the brain.
- You must not have had a bleeding stroke within the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study investigates moyamoya disease, a rare condition where blood vessels in the brain narrow over time. Researchers want to identify genetic and early warning signs by studying people diagnosed with the disease, their blood relatives, and healthy volunteers.
This study looks at how Moyamoya disease changes over time and what predicts outcomes. It uses approved brain imaging and, likely, thinking/memory tests to understand prognosis.
This study looks at why some people with moyamoya disease have trouble with thinking and memory. It may help find better ways to understand and treat these problems.
This study uses MRI scans to watch how brain networks work while you are asleep during moyamoya bypass surgery. It may help doctors understand how the brain adjusts after the procedure.
This study tests whether daily aspirin, a special physical therapy called remote ischemic conditioning (RIC), or both can slow down moyamoya disease, a condition that narrows brain blood vessels and increases stroke risk. Participating may help you manage your condition and possibly prevent it from getting worse.
This trial follows people with moyamoya disease who are treated with medication only, and it also looks at first-degree relatives. The goal is to understand long-term outcomes and whether careful conservative care is beneficial over time.
Hear when a new Moyamoya Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.